HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nittaya Phanuphak Selected Research
Nittaya Phanuphak Research Topics
Disease
45
HIV Infections (HIV Infection)
04/2024 - 10/2008
35
Infections
11/2023 - 02/2004
9
Sexually Transmitted Diseases (Sexually Transmitted Disease)
09/2023 - 09/2003
9
Inflammation (Inflammations)
01/2023 - 01/2016
5
Viremia
01/2023 - 01/2016
5
Syphilis
01/2022 - 01/2018
4
Hepatitis C
01/2022 - 01/2020
3
Papillomavirus Infections
11/2023 - 01/2020
3
Immune Reconstitution Inflammatory Syndrome
11/2022 - 01/2020
3
Disease Progression
10/2022 - 01/2016
3
Tuberculosis (Tuberculoses)
08/2012 - 02/2010
2
Squamous Intraepithelial Lesions
05/2024 - 01/2013
2
Persistent Infection
11/2023 - 01/2018
2
COVID-19
01/2022 - 10/2021
2
Acquired Immunodeficiency Syndrome (AIDS)
01/2017 - 01/2017
1
Neuroinflammatory Diseases
01/2024
1
Leukocytosis (Pleocytosis)
11/2023
1
Gender Dysphoria
11/2022
1
Virus Diseases (Viral Diseases)
01/2022
1
Hepatitis B
01/2022
1
Injection Site Reaction
12/2021
1
Liver Cirrhosis (Hepatic Cirrhosis)
06/2021
1
Lymphopenia (Lymphocytopenia)
01/2021
1
Anus Neoplasms (Anal Cancer)
01/2021
1
Neoplasms (Cancer)
01/2021
1
Dysbiosis
12/2020
1
Vaccinia
01/2020
1
Coinfection
01/2019
1
Bacterial Vaginosis
11/2018
1
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018
1
HIV Seropositivity
01/2018
1
Acute-Phase Reaction
01/2017
1
Fibrosis (Cirrhosis)
01/2017
Drug/Important Bio-Agent (IBA)
17
RNA (Ribonucleic Acid)
IBA
11/2023 - 02/2004
11
Biomarkers (Surrogate Marker)
IBA
09/2023 - 01/2013
7
DNA (Deoxyribonucleic Acid)
IBA
01/2023 - 01/2013
6
Nucleic Acids
IBA
01/2021 - 10/2008
5
Vaccines
IBA
11/2023 - 10/2008
4
Antigens
IBA
01/2022 - 04/2015
4
Amphetamine (Amfetamine)
FDA Link
Generic
01/2020 - 12/2017
3
Antiviral Agents (Antivirals)
IBA
04/2024 - 01/2020
3
Methamphetamine (Desoxyn)
FDA Link
Generic
01/2021 - 01/2020
3
Integrase Inhibitors
IBA
01/2020 - 01/2015
3
Isoniazid (Ftivazide)
FDA Link
Generic
08/2012 - 02/2010
2
dolutegravir
IBA
01/2023 - 01/2019
2
Viral RNA
IBA
01/2023 - 11/2021
2
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2023 - 10/2022
2
C-Reactive Protein
IBA
01/2023 - 01/2017
2
Epitopes
IBA
10/2022 - 01/2021
2
cabotegravir
IBA
12/2021 - 11/2021
2
Emtricitabine (Emtriva)
FDA Link
12/2021 - 01/2018
2
Racivir
IBA
12/2021 - 11/2021
2
Tenofovir (Viread)
FDA Link
12/2021 - 01/2018
2
Integrins
IBA
12/2020 - 01/2018
2
Antibodies
IBA
01/2020 - 01/2016
2
Enzymes
IBA
01/2019 - 10/2008
2
Monoclonal Antibodies
IBA
01/2019 - 01/2018
2
N-acetyltalosaminuronic acid (NAT)
IBA
04/2015 - 10/2008
2
Tuberculin (PPD)
IBA
08/2012 - 03/2012
1
Papillomavirus Vaccines (HPV Vaccines)
IBA
11/2023
1
efavirenz (Sustiva)
FDA Link
01/2023
1
Biological Factors
IBA
01/2023
1
Hormones (Hormone)
IBA
11/2022
1
Hepatitis B Surface Antigens (HBsAg)
FDA Link
01/2022
1
Creatinine
IBA
01/2022
1
Alanine Transaminase (SGPT)
IBA
01/2022
1
Integrases
IBA
12/2021
1
Reagins
IBA
01/2021
1
Chemokine Receptors
IBA
12/2020
1
Ribosomal DNA (rDNA)
IBA
12/2020
1
Histone Deacetylase Inhibitors
IBA
09/2020
1
Vorinostat
FDA Link
09/2020
1
Explosive Agents (Explosives)
IBA
01/2020
1
Indicators and Reagents (Reagents)
IBA
01/2020
1
Nucleosides
IBA
01/2020
1
Reverse Transcriptase Inhibitors
IBA
01/2020
1
Combined Vaccines
IBA
01/2020
1
Protease Inhibitors (Protease Inhibitor)
IBA
01/2020
1
Chemokines
IBA
01/2018
1
Lipopolysaccharide Receptors
IBA
01/2017
1
fibrin fragment D (D-dimer)
IBA
01/2017
1
Interleukin-6 Receptors (Interleukin 6 Receptor)
IBA
01/2017
1
Cytokine Receptor gp130
IBA
01/2017
1
Lipopolysaccharides
IBA
01/2017
1
Fatty Acid-Binding Proteins
IBA
01/2017
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2017
1
Hyaluronic Acid (Hyaluronan)
IBA
01/2017
1
Interleukin-6 (Interleukin 6)
IBA
01/2017
1
Hemoglobins (Hemoglobin)
IBA
01/2017
1
HIV Antigens
IBA
01/2017
Therapy/Procedure
34
Therapeutics
05/2024 - 09/2003
23
Art Therapy
04/2024 - 12/2014
6
Highly Active Antiretroviral Therapy (HAART)
01/2024 - 02/2004
4
Aftercare (After-Treatment)
10/2020 - 01/2015
2
Injections
12/2021 - 11/2021
1
Continuity of Patient Care
01/2022
1
Ambulatory Care (Outpatient Care)
01/2021
1
Secondary Prevention
11/2020
1
Copper Intrauterine Devices
11/2018
1
Condoms (Condom)
12/2017